The approval process involves
several steps including preclinical laboratory and animal studies, clinical trials for safety and efficacy, filing of a
New Drug Application by the manufacturer of the drug, and FDA review and approval of the applicat
Drug Application by the manufacturer of the drug, and FDA review and approval of the a
Application by the manufacturer of the
drug, and FDA review and approval of the applicat
drug, and FDA review and approval of the
applicationapplication.
In connection with this goal, Vanda's management team has been working diligently over the past
several months with the Food &
Drug Administration («FDA») to reevaluate its response to Vanda's
New Drug Application («NDA») for iloperidone for the treatment of schizophrenia.